Table: Phoenixbio -2020/21 group results

PhoenixBio

14/05/2021 08:00

May 14 (Reuters)- 
          Phoenixbio Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended       Year ended       Year to        NEXT    
              Mar 31, 2021     Mar 31, 2020   Mar 31, 2022      YEAR      
                 LATEST          YEAR-AGO        COMPANY       COMPANY    
                 RESULTS         RESULTS        FORECAST     H1 FORECAST  
  Sales           1.01             1.31           1.60         758 mln    
               (-22.7 pct)      (+6.7 pct)                                
  Operating   loss 276 mln     loss 146 mln      92 mln      loss 11 mln  
  Recurring   loss 223 mln     loss 125 mln      91 mln      loss 11 mln  
  Net
  Net         loss 238 mln     loss 415 mln      82 mln      loss 12 mln  
  EPS        loss 73.60 yen  loss 141.84 yen    25.01 yen   loss 3.85 yen 
  Ann Div          NIL             NIL             NIL                    
  -Q2 Div          NIL             NIL             NIL                    
  -Q4 Div          NIL             NIL             NIL                    
  
  NOTE - Phoenixbio Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T